Andrew Kruegel
Kures, inc.
Affiliations
Columbia University
Technologies
Therapeutic
Indication
Basic Research
Central Nervous System Disorders
Pain Management
Website
www.kuresinc.comI am developing improved analogs of the known antidepressant, tianeptine, which acts through a novel mechanism of action, as new therapies for treatment-resistant depression
